Cargando…

The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models

Mesenchymal stem cells (MSCs), discovered and isolated from the bone marrow in the 1960s and with self-renewal capacity and multilineage differentiation potential, have valuable immunomodulatory abilities. Acute kidney injury (AKI) refers to rapid renal failure, which exhibits as quickly progressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tianbiao, Liao, Chunling, Lin, Shujun, Lin, Wenshan, Zhong, Hongzhen, Huang, Shuangyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422493/ https://www.ncbi.nlm.nih.gov/pubmed/32831852 http://dx.doi.org/10.1155/2020/1873921

Ejemplares similares

Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants
por: Lin, Shujun, et al.
Publicado: (2020)

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis
por: Lin, Wenshan, et al.
Publicado: (2021)

Association of hypoxia-inducible factor-1α (HIF1α) 1790G/A gene polymorphism with renal cell carcinoma and prostate cancer susceptibility: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)

All-trans retinoic acid regulating angiopoietins-1 and alleviating extracellular matrix accumulation in interstitial fibrosis rats
por: Zhong, Zhiqing, et al.
Publicado: (2021)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019)

Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population
por: Lin, Shujun, et al.
Publicado: (2019)

Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
por: Lin, Wenshan, et al.
Publicado: (2019)

Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
por: Xing, Li, et al.
Publicado: (2014)

Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia–reperfusion injury
por: Chen, Yen-Ta, et al.
Publicado: (2013)

Association of apoE gene polymorphisms with lipid metabolism in renal diseases
por: Zhou, Tianbiao, et al.
Publicado: (2020)

A rare case report of heavy dose colchicine induced acute kidney injury
por: Zhong, Hongzhen, et al.
Publicado: (2018)

Therapeutic Properties of Mesenchymal Stem Cell on Organ Ischemia-Reperfusion Injury
por: Oliva, Joan
Publicado: (2019)

Association of Nuclear Receptor Coactivators with Hypoxia-Inducible Factor-1α in the Serum of Patients with Chronic Kidney Disease
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury
por: Soares, Rodrigo Zon, et al.
Publicado: (2015)

Relationship between TGF-β1 + 869 T/C and + 915 G/C gene polymorphism and risk of acute rejection in renal transplantation recipients
por: Li, Hong-Yan, et al.
Publicado: (2019)

Localization and Maintenance of Engrafted Mesenchymal Stem Cells Administered via Renal Artery in Kidneys with Ischemia-Reperfusion Injury
por: Yamada, Yumi, et al.
Publicado: (2021)

Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis
por: Liao, Chunling, et al.
Publicado: (2022)

Roles of TRAFs in Ischemia-Reperfusion Injury
por: Zhou, Wei, et al.
Publicado: (2020)

Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory Reaction
por: Chen, Yen-Ta, et al.
Publicado: (2011)

Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy
por: Tseng, Wei-Cheng, et al.
Publicado: (2021)

Mesenchymal Stem Cells-Derived Exosomes Ameliorate Ischemia/Reperfusion Induced Acute Kidney Injury in a Porcine Model
por: Huang, Jianni, et al.
Publicado: (2022)

Dynamics of necroptosis in kidney ischemia-reperfusion injury
por: Pefanis, Aspasia, et al.
Publicado: (2023)

Extracellular vesicles from anoxia preconditioned mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury
por: Mao, Chengyu, et al.
Publicado: (2021)

Mesenchymal Stem Cells Promote the Resolution of Cardiac Inflammation After Ischemia Reperfusion Via Enhancing Efferocytosis of Neutrophils
por: Zhang, Zeyu, et al.
Publicado: (2020)

Mesenchymal stromal cells in renal ischemia/reperfusion injury
por: de Vries, Dorottya K., et al.
Publicado: (2012)

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
por: Rowart, Pascal, et al.
Publicado: (2015)

Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease
por: Wang, Jiali, et al.
Publicado: (2022)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

The HO-1-expressing bone mesenchymal stem cells protects intestine from ischemia and reperfusion injury
por: Yan, Xue-Tao, et al.
Publicado: (2019)

Mesenchymal stem cells attenuate acute ischemia-reperfusion injury in a rat model
por: LU, WEIFENG, et al.
Publicado: (2015)

Inhibition of Myocardial Ischemia/Reperfusion Injury by Exosomes Secreted from Mesenchymal Stem Cells
por: Zhang, Heng, et al.
Publicado: (2016)

Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury
por: Liu, Yung-Yang, et al.
Publicado: (2017)

The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease
por: Zhong, Hongzhen, et al.
Publicado: (2018)

Three-Dimensional Aggregates Enhance the Therapeutic Effects of Adipose Mesenchymal Stem Cells for Ischemia-Reperfusion Induced Kidney Injury in Rats
por: Zhao, Xiaozhi, et al.
Publicado: (2016)

Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014)

Effect of NAD(+) boosting on kidney ischemia-reperfusion injury
por: Morevati, Marya, et al.
Publicado: (2021)

Acute Kidney Injury by Ischemia/Reperfusion and Extracellular Vesicles
por: Nørgård, Mikkel Ørnfeldt, et al.
Publicado: (2023)

Amazonia Phytotherapy Reduces Ischemia and Reperfusion Injury in the Kidneys
por: de Oliveira, Brenner Kássio Ferreira, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5f5saeqiu7ho5of97ou1fm80rh